CMS Sets Oct. 1 Launch for First-Ever Medicare 340B Data Repository

CMS
CMS recently released new materials detailing the upcoming implementation of its new Medicare Part D 340B data repository.
CMS is set to begin accepting voluntary Medicare Part D claims data from covered entities next month through its first-ever [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Michigan Hospital Sues HRSA Over 340B Eligibility Dispute

Corewell Health
Beaumont Hospital, part of Michigan-based Corewell Health, recently sued HRSA over a 340B eligibility dispute. (Photo: Wikimedia/WMrapids)
A Michigan teaching hospital recently sued HRSA in a Washington, D.C., federal court, arguing that the agency’s “unlawful” registration process [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »
Industry Insights Logo

340B Compliance Workshop: In-Depth Training on 340B Program Requirements and Developments

SPONSORED CONTENT

340B program compliance seems to become more complicated each year, with new reporting obligations, scrutiny and expectations. Even seasoned 340B program health center staff can feel overwhelmed by the volume and pace of developments in the

Read More »

New PhRMA Ad Targets Hospital 340B ‘Markups,’ RWC-340B Shows 340B in ‘Real World’

PhRMA released a new football-themed ad Wednesday alleging that “nonprofit hospitals score big on 340B markups.”
Washington D.C.’s most powerful drug industry trade group this week again took aim at hospitals’ use of 340B savings, while [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Editorial Team Unveils New 340B Explainer, Talks History and Recent Developments

The 340B Report editorial team hosted a webinar open to subscribers and non-subscribers on Sept. 9.
340B Report’s editorial team announced the news service’s new 340B explainer resource and discussed the program’s history and key tension [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Takeda Adds Blood Cancer Drug to CP Restrictions Policy

Takeda logo
Takeda has added 340B contract pharmacy restrictions to blood cancer treatment drug Mimrylo.
A Japanese pharmaceutical giant this week announced that it has added a blood cancer treatment to its list of drugs [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »
340B Solutions Spotlight

Q: What is the primary problem Accelerate Pharmacy Solutions solves?

Accelerate Pharmacy Solutions 340B Consulting helps healthcare organizations address the operational, financial, and compliance complexity of…

Read More »

J&J Adds 340B In-House Data Reqs, Extends Contract Pharmacy Restrictions to Grantees

Johnson & Johnson (J&J)
J&J added new in-house pharmacy 340B data requirements and expanded its existing contract pharmacy restrictions to 340B grantees.
Pharmaceutical giant Johnson & Johnson (J&J) recently announced it will soon expand its 340B claims data requirements to include in-house [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Congressional Drug Pricing Report Looks at State 340B Actions

Screenshot CRS report cover.
The Congressional Research Service examined state 340B laws’ effects on drug pricing as part of an Aug. 31 report.
A new congressional report on state efforts to lower prescription drug prices highlighted the growing number of states that have [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »
Industry Insights Logo

Why Finding a 340B Referral Isn’t the Same as Capturing It

SPONSORED CONTENT

Artificial Intelligence (AI) is reshaping 340B referral capture, and it is only ramping up from here. I have seen that firsthand working with hundreds of covered entities (CE) over the last four years. Here is what AI does well:

  • Identifying referral
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live